Press ESC to close

Peptide Lab App Log in Articles Guide Products
More Peptide Tracker Calculator Best Calculators Peptide Statistics Contact Newsletter
Français English Deutsch Español Português العربية Italiano Polski 한국어 日本語 中文 RU

All Our Peptide Articles

Complete guides, comparisons and scientific analyses on peptides in skincare, health and biohacking.

169 Articles
Microdosing GLP-1 Drugs: Separating the Trend From the Evidence
Health October 3, 2026

Microdosing GLP-1 Drugs: Separating the Trend From the Evidence

A neutral look at a practice that spread through social media and some clinics faster than any study could follow it.

Are Peptides Legal? A Jurisdiction by Jurisdiction Guide
Guide September 30, 2026

Are Peptides Legal? A Jurisdiction by Jurisdiction Guide

Approved prescription medicines, vials labeled 'for research use only', cosmetics and food supplements do not share the same legal status. Here is what the official texts say, as of September 30, 2026.

Bacteriostatic Water: What It Is, What Benzyl Alcohol Does, and How It Is Stored
Guide October 1, 2026

Bacteriostatic Water: What It Is, What Benzyl Alcohol Does, and How It Is Stored

A reference guide to the preserved diluent found in multi-dose vials: composition, labeled indications, shelf life after first entry, and the documented neonatal contraindication.

Retatrutide Side Effects: A Review of the Published Trial Evidence
Health September 28, 2026

Retatrutide Side Effects: A Review of the Published Trial Evidence

Retatrutide is an investigational triple GIP, GLP-1 and glucagon receptor agonist. This review covers only the adverse effects reported in peer-reviewed trials and registrational readouts, always alongside the placebo comparison.

Klow vs MOTS-c: Two Different Questions, Two Different Peptides
Comparison September 23, 2026

Klow vs MOTS-c: Two Different Questions, Two Different Peptides

Klow Blend targets tissue repair, skin and inflammation. MOTS-c is a mitochondrial-encoded peptide studied for metabolism and exercise capacity. Here is how they actually compare, and what the literature does and does not say about combining them.

MOTS-c Side Effects: A Safety Profile Built on Very Little Human Data
Health 20 September 2026

MOTS-c Side Effects: A Safety Profile Built on Very Little Human Data

What animal studies report, what the single human trial of a MOTS-c analog found, and why the honest answer to "is it safe?" is still "nobody knows."

MOTS-c Dosage: What the Research Actually Administered
Guide September 19, 2026

MOTS-c Dosage: What the Research Actually Administered

A source-by-source look at every documented MOTS-c dose, why no validated human protocol exists, and how to read a vial label without guessing.

AHK-Cu Peptide: What the Science Actually Shows
Science September 11, 2026

AHK-Cu Peptide: What the Science Actually Shows

A rigorous look at alanyl-histidyl-lysine copper, the lesser known cousin of GHK-Cu: its chemistry, the mechanisms studied in cell culture, and where the evidence genuinely stops.

The Peptide Dosage Chart: Vial Size, Water Volume, Concentration, Units
Guide September 8, 2026

The Peptide Dosage Chart: Vial Size, Water Volume, Concentration, Units

A reference table, not a protocol. One rule (1 unit = 0.01 mL) converts any vial size and any volume of bacteriostatic water into micrograms per syringe unit.

Zepbound Before and After: What the Published Data Actually Show
Health September 08, 2026

Zepbound Before and After: What the Published Data Actually Show

A week-by-week look at tirzepatide outcomes in the SURMOUNT trials, and the things a before-and-after photo can never tell you.

Melanotan 2 Before and After: A Science-Based Look at Results and Risks
Health September 01, 2026

Melanotan 2 Before and After: A Science-Based Look at Results and Risks

What peer-reviewed research describes about pigmentation timelines, plausible tanning phases, documented adverse effects, and the unresolved safety and regulatory questions surrounding this alpha-MSH analog.

Retatrutide Results Timeline: What the Phase 2 Trials Actually Show
Health 01 September 2026

Retatrutide Results Timeline: What the Phase 2 Trials Actually Show

A neutral, data-driven look at how fast weight loss appears with the triple GIP/GLP-1/glucagon agonist, dose by dose and month by month.